drugset / Trial / NCT00565591

Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI

NCT00565591

Phase 1 Completed 12 enrolled Respirics Inc.
Non-randomizedSingle-groupSingle-blindTreatment

Summary

This open label single blind study will determine the safety of albuterol sulfate dry powder in a novel inhaler by observing for the potential occurrence of reflex bronchial constriction after inhalation of increasing doses of the compound.

Timeline

Start
2007-11
Primary completion
2008-01
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Salbutamol Unknown Inhaled

Indications